Literature DB >> 30114958

A positive psychology-motivational interviewing intervention for patients with type 2 diabetes: Proof-of-concept trial.

Christopher M Celano1, Taylor A Gianangelo2, Rachel A Millstein2, Wei-Jean Chung2, Deborah J Wexler3, Elyse R Park2, Jeff C Huffman2.   

Abstract

OBJECTIVE: Eighteen million Americans with type 2 diabetes (T2D) do not follow recommended guidelines for physical activity. Motivational interviewing (MI) has had modest effects on activity and related behaviors in T2D. Positive psychological attributes (e.g., optimism) are associated with superior medical outcomes in T2D, and positive psychology (PP) interventions promote such attributes. There had been no study in T2D of a combined PP-MI intervention to promote well-being and health behavior adherence. We developed a novel, telephone-delivered, 16-week PP-MI intervention and explored its feasibility and impact in T2D patients in a single-arm, proof-of-concept trial.
METHOD: Participants completed PP-based exercises and MI-based physical activity goal-setting activities and reviewed these activities weekly with a study trainer for 16 weeks. Feasibility and acceptability were assessed via exercise completion rates and post-exercise ratings of ease/utility (0-10 scales). Impact was explored by examining changes in physical activity (via accelerometers and self-report), other health behaviors, psychological measures, and medical outcomes (e.g., hemoglobin A1c (A1C)) from baseline to 16 weeks, using paired t tests.
RESULTS: Twelve participants enrolled, and 10 provided follow-up data. Seventy-eight percent of PP-MI activities were completed, and participants rated the PP-MI content and sessions as easy (mean = 8.2/10, standard deviation (SD) = 1.9) and useful (mean = 9.1/10, SD = 1.5). PP-MI was associated with improved adherence to health behaviors and overall self-care, variable effects on accelerometer-measured activity and psychological outcomes, and modest beneficial effects on body mass index and A1C.
CONCLUSION: Further testing of this intervention is warranted in a larger, controlled trial to assess its effects on important health outcomes.

Entities:  

Keywords:  diabetes; health behavior; motivational interviewing; optimism; physical activity; positive affect; positive psychology

Mesh:

Year:  2018        PMID: 30114958      PMCID: PMC6370502          DOI: 10.1177/0091217418791448

Source DB:  PubMed          Journal:  Int J Psychiatry Med        ISSN: 0091-2174            Impact factor:   1.210


  11 in total

1.  Feasibility and preliminary efficacy of a positive psychology-based intervention to promote health behaviors in heart failure: The REACH for Health study.

Authors:  Christopher M Celano; Melanie E Freedman; Lauren E Harnedy; Elyse R Park; James L Januzzi; Brian C Healy; Jeff C Huffman
Journal:  J Psychosom Res       Date:  2020-10-29       Impact factor: 3.006

Review 2.  Positive Psychology and Hope as Lifestyle Medicine Modalities in the Therapeutic Encounter: A Narrative Review.

Authors:  Ashten R Duncan; Paresh A Jaini; Chan M Hellman
Journal:  Am J Lifestyle Med       Date:  2020-03-03

3.  Developing a Psychological-Behavioral Intervention in Cardiac Patients Using the Multiphase Optimization Strategy: Lessons Learned From the Field.

Authors:  Jeff C Huffman; Rachel A Millstein; Christopher M Celano; Brian C Healy; Elyse R Park; Linda M Collins
Journal:  Ann Behav Med       Date:  2020-02-21

4.  A positive psychology-motivational interviewing program to promote physical activity in type 2 diabetes: The BEHOLD-16 pilot randomized trial.

Authors:  Jeff C Huffman; Julia Golden; Christina N Massey; Emily H Feig; Wei-Jean Chung; Rachel A Millstein; Lydia Brown; Taylor Gianangelo; Brian C Healy; Deborah J Wexler; Elyse R Park; Christopher M Celano
Journal:  Gen Hosp Psychiatry       Date:  2020-12-11       Impact factor: 3.238

5.  A Positive Psychology-Motivational Interviewing Intervention to Promote Positive Affect and Physical Activity in Type 2 Diabetes: The BEHOLD-8 Controlled Clinical Trial.

Authors:  Jeff C Huffman; Julia Golden; Christina N Massey; Emily H Feig; Wei-Jean Chung; Rachel A Millstein; Lydia Brown; Taylor Gianangelo; Brian C Healy; Deborah J Wexler; Elyse R Park; Christopher M Celano
Journal:  Psychosom Med       Date:  2020-09       Impact factor: 3.864

6.  A community-based positive psychology group intervention to promote physical activity among people with metabolic syndrome: Proof of concept results to inform a pilot randomized controlled trial protocol.

Authors:  Rachel A Millstein; Anne N Thorndike; Sonia Kim; Elyse R Park; Jeff C Huffman
Journal:  Contemp Clin Trials Commun       Date:  2020-07-16

7.  Exploring the feasibility and impact of positive psychology-motivational interviewing interventions to promote positive affect and physical activity in type 2 diabetes: design and methods from the BEHOLD-8 and BEHOLD-16 clinical trials.

Authors:  Juliana Zambrano; Christopher M Celano; Wei-Jean Chung; Christina N Massey; Emily H Feig; Rachel A Millstein; Brian C Healy; Deborah J Wexler; Elyse R Park; Julia Golden; Jeff C Huffman
Journal:  Health Psychol Behav Med       Date:  2020-09-14

8.  A phone and text message intervention to improve physical activity in midlife: initial feasibility testing.

Authors:  Jeff C Huffman; Lauren E Harnedy; Christina N Massey; Alba Carrillo; Emily H Feig; Wei-Jean Chung; Christopher M Celano
Journal:  Health Psychol Behav Med       Date:  2022-03-10

9.  Latent growth curve modeling of physical activity trajectories in a positive-psychology and motivational interviewing intervention for people with type 2 diabetes.

Authors:  Rachel A Millstein; Julia Golden; Brian C Healy; Hermioni L Amonoo; Lauren E Harnedy; Alba Carrillo; Christopher M Celano; Jeff C Huffman
Journal:  Health Psychol Behav Med       Date:  2022-08-04

10.  Effect of motivational interviewing intervention on HgbA1C and depression in people with type 2 diabetes mellitus (systematic review and meta-analysis).

Authors:  Kalayou Kidanu Berhe; Haftu Berhe Gebru; Hailemariam Berhe Kahsay
Journal:  PLoS One       Date:  2020-10-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.